ALung

Pittsburgh, United States Founded: 1997 • Age: 29 yrs Acquired By LivaNova
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.

About ALung

ALung is a Healthcare company based in Pittsburgh (United States) founded in 1997, and was acquired by LivaNova in May 2022. Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation. ALung has raised $130.87 million across 23 funding rounds from investors including UPMC, Abiomed and LivaNova. ALung offers products and services including Essenzâ„¢ Perfusion System, VNS Therapyâ„¢ for Epilepsy, and VNS Therapyâ„¢ for Depression. Its focus areas include Life Sciences, Pulmonology, Medical Devices and Therapeutic Devices. Its legal entity is LivaNova PLC. Its competitors include Belluscura, Brio Device and Securisyn; 3 of its 3 listed competitors have raised funding.

Company details

ALung was founded in 1997 in Pittsburgh, United States, and operates within the medical technology sector. Extracorporeal CO2 removal systems are developed to support mechanical ventilation for patients. The Hemolung Cartridge is integrated with a centrifugal blood pump and gas exchange membrane as a single device. Focus is placed on respiratory assistance technologies, with headquarters maintained in Pittsburgh.

Operational Areas
Key Metrics
  • Total Equity Funding
    $130.87M (USD)

    in 23 rounds

  • Latest Funding Round
    $1.81M (USD), Series C

    May 2021

  • Investors
    UPMC

    & 13 more

  • Acquired by
    LivaNova

    (May 2022)

Products & Services of ALung

ALung offers a comprehensive portfolio of products and services, including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression.

Essenz™ Perfusion System
Medical Device

System for cardiopulmonary support during surgeries

VNS Therapy™ for Epilepsy
Therapy Device

Implantable device to treat drug-resistant epilepsy

VNS Therapy™ for Depression
Therapy Device

Device for managing difficult-to-treat depression symptoms

Apps and channels of ALung

its YouTube channel LivaNova has 1.24K subscribers and 23 videos.

LivaNova
YouTube 1.24K subscribers 23 videos Autos & Vehicles
Open channel

Videos from ALung

The most watched videos on ALung's YouTube channel, LivaNova (1.24K subscribers). Click a video to play it here.

A Medtech Pioneer United in Mission
310 views
Work That Matters: Mirandola
209 views
A Day in the Life of a LivaNova Sales Area Manager: Meet Claudio from Italy
202 views
Change Lives with a LivaNova Career in Medtech
199 views

More on LivaNova.

Funding Insights of ALung

ALung has successfully raised a total of $130.87M across 23 strategic funding rounds. The most recent funding activity was a Series C round of $1.81 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $130.87M
  • Total Rounds 23
  • Last Round Series C — $1.81M
  • First Round $1.17M

    (Jun 2002)

  • Investors Count 13

Latest 10 of 23 funding rounds of ALung with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2021$1.81MSeries C––
–
Nov 2020$5.44MSeries C––
–
Jun 2020$2MSeries C––
–
Feb 2020$3.26MSeries C––
–
Feb 2020$3MSeries C––
–
Aug 2019$5MSeries C––
–
Jan 2019$5MSeries C––
–
Mar 2017$37.54MSeries C–UPMC, Philips Ventures
Feb 2017$2.6MSeries C––
–
Feb 2016$12MSeries C––
–
Valuation history

14 investors in total: 14 institutional.

Investors in ALung

ALung has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include UPMC, Abiomed and LivaNova.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
acceleratorfund.com
Venture capital is provided to high-potential tech companies in the Midwest.
allosventures.comCincinnati, United States
US focused early-stage VC firm investing in tech & life sciences start-ups
birchmerevc.comPittsburgh, United States
Early-stage venture capital funding is provided by Riverfront Ventures.
riverfrontventures.comPittsburgh, United States
ventures.philips.com
Support is offered for life sciences startups in Pittsburgh.
2002plsg.comPittsburgh, United States
eagleventures.biz
Multispecialty hospitals are operated as a nationwide chain.
1986upmc.comUnited States
Heart pumps are developed for blood circulation and oxygenation support.
1981abiomed.comDanvers, United States
bluetreeventurefund.com
Premium access

Investor details for ALung

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ALung

2 people are tracked at ALung (2 in team).

NameRoleGroup
Tracey Dill
Sr. Manager Clinical Field OperationsTeam
Missy Nibert
Clinical SpecialistTeam
Premium access

Complete people profiles for ALung

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ALung

4 dated milestones of ALung across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded ALung is founded.
  2. Funding First funding round of $1.2M.
  3. Funding Latest funding round, Series C, of $1.8M.
  4. Exit Acquired by LivaNova.

Competitors of ALung

ALung has 3 listed competitors in our database, 3 of them funded. They include Belluscura, Brio Device and Securisyn.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
belluscura.com2015Dallas, United States$6.38M21
Provider of medical devices for laparoscopic procedures
briodevice.com2010Doylestown, United States$1.94M
Medical devices for emergency airway management are developed.
securisyn.com2011Denver, United States$16.79M
Endotracheal tube stabilization systems for ventilated patients are developed.
Premium access

Detailed competitors of ALung

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ALung

Websites that share an audience with ALung (alung.com).

Similar websites

Websites whose visitors overlap most with ALung. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
pei.ie
pei.ie
100%
#5,806,981–
medgadget.com
medgadget.com
96%
–
medicinajoven.com
medicinajoven.com
96%
–
ipcrg.org
63%
16.5K#1,629,631View details

Top companies in Pulmonology

3 companies that operate in the same segment as ALung (Pulmonology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of novel protein-based therapeutics using machine learning and biological engineering
2018Somerville, Massachusetts, United StatesUSD 693 M329
Portable oxygen concentrators are supplied for respiratory therapy needs.
2001Goleta, California, United StatesUSD 51.65 MUSD 348.67 M766
Robotic microsurgical systems for endoscopy are developed.
2007Redwood City, California, United StatesUSD 733.62 M91
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Alung

Premium access

Complete news archive for ALung

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ALung

ALung was founded in 1997 and raised its 1st funding round 5 years after it was founded.

ALung is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.

ALung is a funded company, having raised a total of $130.87M across 23 funding rounds to date. The company's 1st funding round was a Series C of $12M, raised on Jun 2002.

ALung was founded in 1997 in Pittsburgh, United States, and operates within the medical technology sector. Extracorporeal CO2 removal systems are developed to support mechanical ventilation for patients. The Hemolung Cartridge is integrated with a centrifugal blood pump and gas exchange membrane as a single device. Focus is placed on respiratory assistance technologies, with headquarters maintained in Pittsburgh.

ALung's top competitors include Belluscura, Brio Device and Securisyn.

ALung offers Essenzâ„¢ Perfusion System, VNS Therapyâ„¢ for Epilepsy, and VNS Therapyâ„¢ for Depression.

ALung has 14 investors. Key investors include UPMC, Abiomed, LivaNova, West Capital Advisors, and Pittsburgh Life Sciences Greenhouse.

ALung operates through Livanova Plc.

Yes. ALung was acquired by LivaNova in May 2022.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available